Surgical outcomes of N2 and T3-4 non-small cell lung cancer

Watanabe, Yoh

doi:10.1016/j.lungcan.2003.08.007

Cited by 4 publications

(2 citation statements)

References 25 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Adequate staging before surgery is, thus, of paramount importance to better stratify the therapeutic approach and to limit the number of futile thoracotomies. In particular, patients with N2 mediastinal lymph node involvement are poor candidates for initial surgical resection, since 5-yr survival rate in this condition ranges, according to various series, from 11-30% only [2].…”

mentioning

confidence: 99%

Endobronchial ultrasound and positron emission tomography positive mediastinal lymph nodes

Plat

Pierard²,

Haller³

et al. 2006

Eur Respir J

View full text Add to dashboard Cite

Positron emission tomography with 18F-fluoro-2-deoxy-D-glucose (FDG-PET) is more accurate than computed tomography for staging of mediastinal (hilar) lymph nodes. In the case of positive findings, tissue sampling of lymph nodes is required. The diagnostic/staging yield of transbronchial needle aspiration (TBNA) following endobronchial ultrasound (EBUS) localisation was assessed in this particular clinical setting. The number of avoided surgical procedures was evaluated.All consecutive patients referred for staging and/or diagnosis of mediastinal FDG-PET positive lesions were included. Data were prospectively collected. TBNA sampling of lymph nodes was performed after EBUS localisation. If no diagnosis was reached, further surgical sampling or adequate follow-up was performed.From January 2003 to June 2004, 33 patients were included. The average number of TBNA samples per patient was 4.2¡1.5. Cytological or histological diagnoses were obtained in 27 (82%) of the patients, of which 78% were obtained after previous EBUS localisation. In 25 (76%) of the 33 patients, surgical staging procedures were suppressed.In conclusion, transbronchial needle aspiration after endobronchial ultrasound localisation should be considered as a primary method of evaluation of lymph nodes positive by positron emission tomography with 18F-fluoro-2-deoxy-D-glucose, and may replace the majority of surgical mediastinal staging/diagnostic procedures.

show abstract

mentioning

confidence: 99%

Endobronchial ultrasound and positron emission tomography positive mediastinal lymph nodes

Plat

Pierard²,

Haller³

et al. 2006

Eur Respir J

View full text Add to dashboard Cite

show abstract

“…In patients with T4 tumour, complete resection is not always possible because of the invasion of the mediastinal organs. However, complete resection performed in selected patients offers a longer survival than all other treatments available (1).…”

Section: Introductionmentioning

confidence: 99%

Resection via Median Sternotomy in Patients with Lung Cancer Invading the Main Pulmonary Artery

Şanlı

Işık

Tunçözgür

et al. 2009

Acta Chirurgica Belgica

View full text Add to dashboard Cite

Standard posterolateral thoracotomy might not be possible in all cases, particularly in patients with hilar tumours invading the main pulmonary artery. In such patients an intrapericardial approach with median sternotomy provides an easier and safer alternative while making it possible to have wider lymph node dissection. Furthermore, if necessary, hemi-clamshell incision can easily be added to this approach.

show abstract

Échographie endobronchique et ganglions TEP positives dans le cancer broncho-pulmonaire

Faber

Pierard²,

Prigogine³

et al. 2006

Revue des Maladies Respiratoires

View full text Add to dashboard Cite

Surgical outcomes of N2 and T3-4 non-small cell lung cancer

Cited by 4 publications

References 25 publications

Endobronchial ultrasound and positron emission tomography positive mediastinal lymph nodes

Endobronchial ultrasound and positron emission tomography positive mediastinal lymph nodes

Resection via Median Sternotomy in Patients with Lung Cancer Invading the Main Pulmonary Artery

Échographie endobronchique et ganglions TEP positives dans le cancer broncho-pulmonaire

Contact Info

Product

Resources

About